What are the trials’ target populations?
PROMISE seeks men >45 years and women >50 years, without known CAD, who require an initial evaluation of stable symptoms suspicious for CAD. RESCUE seeks patients ages 40 or older with symptoms of angina without prior revascularization, regardless of prior evaluation, known CAD or acute presentation.